Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Zara J Franklin"'
Autor:
Zara J, Franklin, Ryan A, Lafferty, Peter R, Flatt, Laura M, McShane, Finbarr P M, O'Harte, Nigel, Irwin
Publikováno v:
Biochimie. 199:60-67
Ablation of glucagon receptor (GCGR) signalling is a potential treatment option for diabetes, whilst glucagon-like peptide-1 (GLP-1) receptor agonists are clinically approved for both obesity and diabetes. There is a suggestion that GCGR blockade enh
Autor:
Luis Fernando Delgadillo-Silva, Anastasia Tsakmaki, Nadeem Akhtar, Zara J. Franklin, Judith Konantz, Gavin A. Bewick, Nikolay Ninov
Publikováno v:
Disease Models & Mechanisms, Vol 12, Iss 1 (2019)
Islet inflammation and cytokine production are implicated in pancreatic β-cell dysfunction and diabetes pathogenesis. However, we lack therapeutics to protect the insulin-producing β-cells from inflammatory damage. Closing this clinical gap require
Externí odkaz:
https://doaj.org/article/7f5ba0f044434aa0811b586038338678
Autor:
Ryan A Lafferty, Laura M McShane, Zara J Franklin, Peter R Flatt, Finbarr P M O’Harte, Nigel Irwin
Publikováno v:
The Journal of endocrinology. 255(2)
Discerning modification to the amino acid sequence of native glucagon can generate specific glucagon receptor (GCGR) antagonists, that include desHis1Pro4Glu9-glucagon and the acylated form desHis1Pro4Glu9(Lys12PAL)-glucagon. In the current study, we
Autor:
Zara J. Franklin, Patricia Fonseca Pedro, Shanta J. Persaud, Guo Cai Huang, Aileen King, Gavin A. Bewick, Anastasia Tsakmaki, Sakeena Amjad
Publikováno v:
Franklin, Z J, Tsakmaki, A, Fonseca Pedro, P, King, A J, Huang, G C, Amjad, S, Persaud, S J & Bewick, G A 2017, ' Islet neuropeptide Y receptors are functionally conserved and novel targets for the preservation of beta-cell mass ', Diabetes, obesity & metabolism . https://doi.org/10.1111/dom.13119
Aims: Two unmet therapeutic strategies for diabetes treatment are prevention of beta-cell death and stimulation of beta-cell replication. Our aim was to characterize the role of neuropeptide Y receptors in the control of beta-cell mass. Materials and
Autor:
Pratik Choudhary, Astrid C Hauge-Evans, Guo Cai Huang, Bo Liu, Peter M. Jones, Zara J. Franklin, Shanta J. Persaud, Alonso Vilches-Flores
Publikováno v:
BBA Clinical
Vilches-Flores, A, Franklin, Z, Hauge-Evans, A C, Liu, B, Huang, G C, Choudhary, P, Jones, P M & Persaud, S J 2016, ' Prolonged activation of human islet cannabinoid receptors in vitro induces adaptation but not dysfunction ', BBA Clinical . https://doi.org/10.1016/j.bbacli.2016.03.009
Vilches-Flores, A, Franklin, Z, Hauge-Evans, A C, Liu, B, Huang, G C, Choudhary, P, Jones, P M & Persaud, S J 2016, ' Prolonged activation of human islet cannabinoid receptors in vitro induces adaptation but not dysfunction ', BBA Clinical . https://doi.org/10.1016/j.bbacli.2016.03.009
Background Although in vivo studies have implicated endocannabinoids in metabolic dysfunction, little is known about direct, chronic activation of the endocannabinoid system (ECS) in human islets. Therefore, this study investigated the effects of pro
Publikováno v:
Journal of Endocrinology. 225:19-26
The inhibitory effect of somatostatin (SST) on insulin secretionin vivois attributed to a direct effect on pancreatic beta cells, but this is inconsistent with somein vitroresults in which exogenous SST is ineffective in inhibiting secretion from iso
Autor:
Aileen King, Stefan Amisten, Astrid C Hauge-Evans, Zara J. Franklin, Alonso Vilches-Flores, Christina Reers, Alan Kerby, Shanta J. Persaud, Peter M. Jones, Z Tippu, Zoheb Hassan
Publikováno v:
Diabetes, Obesity and Metabolism. 16:947-956
Aims Islets are innervated by parasympathetic nerves which release acetylcholine (ACh) to amplify glucose-induced insulin secretion, primarily via muscarinic M3 receptors (M3R). Here we investigate the consequence of chronic hyperglycaemia on islet M
Publikováno v:
Molecular and Cellular Endocrinology. 381:26-34
Acute in vitro and in vivo biological activities of four novel structural analogues of glucagon were tested. desHis(1)Pro(4)-glucagon, desHis(1)Pro(4)Glu(9)-glucagon, desHis(1)Pro(4)Glu(9)Lys(12)FA-glucagon and desHis(1)Pro(4)Glu(9)Lys(30)FA-glucagon
Publikováno v:
Biological Chemistry. 395:433-442
Glucagon is a hormone with important effects on blood glucose regulation. This study has utilized the stable glucagon receptor antagonists, desHis1Pro4Glu9-glucagon and desHis1Pro4Glu9(Lys12PAL)-glucagon, to evaluate the effects of sustained inhibiti
Autor:
Zara J. Franklin, Nigel Irwin, Finbarr O'Harte, D O'Flynn, Laura McShane, Chandralal M. Hewage
Publikováno v:
JOURNAL OF ENDOCRINOLOGY
Ablation of glucagon receptor signaling represents a potential treatment option for type 2 diabetes (T2DM). Additionally, activation of glucose-dependent insulinotropic polypeptide (GIP) receptor signaling also holds therapeutic promise for T2DM. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::754f19b106f4c5b90da88d443bd5ce21